NASDAQ:SEER
Seer Inc Stock News
$1.72
-0.0600 (-3.37%)
At Close: Jun 17, 2024
Seer to Report Second Quarter 2022 Financial Results on August 9, 2022
04:05pm, Thursday, 14'th Jul 2022
REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report finan
Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2022 Results - Earnings Call Transcript
11:01pm, Friday, 06'th May 2022
Seer, Inc. (NASDAQ:SEER ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - Founder, Chairman & CEO David Horn - CFO Omead Ostadan - Pr
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
07:33pm, Wednesday, 04'th May 2022
Seer, Inc. (SEER) delivered earnings and revenue surprises of 7.32% and 18.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Seer to Present at the BofA Securities 2022 Healthcare Conference
04:05pm, Thursday, 28'th Apr 2022
REDWOOD CITY, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company w
Seer to Report First Quarter Financial Results on May 4, 2022
04:05pm, Thursday, 07'th Apr 2022
REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report fina
Seer hires Scott Thomas as chief commercial officer
08:12pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Seer (SEER) appointed Scott D. Thomas as chief commercial officer effective Mar. 21. Thomas joins SEER from Singular Genomics, where he served as SVP, sales and marketing.
Seer stock falls despite Q4 revenue soaring 813% Y/Y
02:46pm, Tuesday, 01'st Mar 2022 Seeking Alpha
Seer <> stock fell despite Q4 revenues rose 812.5% Y/Y to $3.07M.The increase was due to growth in sales of the Proteograph Product Suite, including SP100 instruments, consumable…
Seer, Inc. (SEER) Q4 2021 Earnings Call Transcript
10:00am, Tuesday, 01'st Mar 2022 The Motley Fool
SEER earnings call for the period ending December 31, 2021.
Seer, Inc. (SEER) CEO Omid Farokhzad on Q4 2021 Results - Earnings Call Transcript
01:57am, Tuesday, 01'st Mar 2022 Seeking Alpha
Seer GAAP EPS of -$0.32 in-line, revenue of $3.1M beats by $0.87M
09:24pm, Monday, 28'th Feb 2022 Seeking Alpha
Seer press release (SEER): Q4 GAAP EPS of -$0.32 in-line.Revenue of $3.1M (vs
Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Outlook
09:05pm, Monday, 28'th Feb 2022 GlobeNewswire
Demonstrated tangible market progress and shipped 17 instruments through year end 2021 Demonstrated tangible market progress and shipped 17 instruments through year end 2021
Seer, Inc. (SEER) CEO Omid Farokhzad on Q4 2021 Results - Earnings Call Transcript
08:57pm, Monday, 28'th Feb 2022
Seer, Inc. (SEER) CEO Omid Farokhzad on Q4 2021 Results - Earnings Call Transcript
Seer to Present at the Cowen 42nd Annual Health Care Conference
04:05pm, Tuesday, 22'nd Feb 2022
REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company wi
AAP’s education model in Delhi inspired by Guru Ravidas, Ambedkar: Sanjay Singh
10:30am, Wednesday, 16'th Feb 2022 The Print India
Varanasi, Feb 16 (PTI) The education model presented by the Aam Aadmi Party (AAP) in Delhi is derived from the thoughts of Guru Ravidas and B R Ambedkar, party leader Sanjay Singh said here on Wednesday. Singh, the AAP’s in-charge for Uttar Pradesh, said this after paying obeisance at the Guru Ravidas temple at Seer […]
Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021
09:05pm, Tuesday, 01'st Feb 2022 GlobeNewswire
REDWOOD CITY, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, February 28, 2022. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
